Genome Canada Annual Report 2016-17 41 • an executive committee, • an audit and investment committee, • a governance, election and compensation committee, • a communications and outreach committee, and • a programs committee. The board has in place a science and industry advisory committee that provides advice to the board on approaches and directions that contribute to the achievement of Genome Canada’s strategic plan. This committee consists of individu- als from Canada and abroad who are internationally recognized in the science and industry sectors and in fields relevant to genomics in society. GOVERNANCE Genome Canada is governed by a board of directors comprising no less than nine, but not more than 16, directors. The directors are recruited from the academic, private and public sectors and offer a range of expertise, including genomics research, genomics in society, bioinformatics, academia, the government sector, business, commercialization and communications. New directors are appointed for two-year terms that are renewable. The presidents of each of the following organizations – the Canada Foundation for Innovation, Canadian Institutes of Health Research, National Research Council Canada, Natural Sciences and Engineering Research Council of Canada, and Social Sciences and Humanities Research Council of Canada – are non-voting, ex officio advisers to the board. The board has stewardship over the business and affairs of Genome Canada. Its fiduciary responsibilities include strategic leadership, succession planning, risk mitigation, performance and evaluation, and financial oversight. A number of permanent committees assist the board in fulfilling its duties: Board of directors 4 Audit and investment committee 4 Governance, election and compensation committee 4 Communications and outreach committee 4 Programs committee 4 Science and advisory committee 5 NUMBER OF MEETINGS HELD BY THE BOARD AND ITS COMMITTEES IN 2016-17